Exodus Point Capital Management, LP Oncternal Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 19, 2022	SELL	$0.7 - $1.56 $8,456 - $18,844	-12,080 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.37 - $2.43 $233,464 - $414,101	-170,412 Reduced 93.38%	12,080 $17,000
Q4 2021 Feb 11, 2022	BUY	$2.27 - $4.39 $42,601 - $82,387	18,767 Added 11.46%	182,492 $414,000
Q3 2021 Nov 15, 2021	BUY	$3.37 - $4.76 $551,753 - $779,331	163,725 New	163,725 $683,000
Q2 2021 Aug 16, 2021	SELL	$4.75 - $9.39 $449,164 - $887,927	-94,561 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.59 - $9.04 $434,034 - $854,831	94,561 New	94,561 $787,000
Q4 2019 Feb 14, 2020	SELL	$3.75 - $6.11 $49,500 - $80,652	-13,200 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$3.87 - $6.13 $51,084 - $80,916	13,200 New	13,200 $66,000

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $76.1M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.